Looking Forward: 2022 Strategic Planning
Ruth O'Regan

Happy new year! 2021 was a year we won't forget, and we thank you again for delivering care of the highest order while enduring the challenges of the COVID-19 pandemic. As 2022 begins, we want to look forward to our future: developing a cultural evolution for the department. Our first step is to build a comprehensive, multi-year strategic plan for 2022-2025.

The plan will focus on education, clinical care, research, and community engagement, while advancing diversity and inclusion across all of our missions. It will be led by myself and vice-chair of Finance & Administration, Tim Heffer. The desire is to break down silos and build on collaboration and teamwork, while finding a balance of professionalism and family life. Work on the plan will kick off in February, and we aim to finalize and activate the plan in May.

We will look to department leaders, division chiefs, and representatives from faculty, APP's, staff, administration, and regional sites for input, guidance, and feedback throughout the process. We are excited to usher in a new era of the department and will share updates with you as we progress.

Be well,
Ruth O'Regan, M.D.

    Top Stories  
DOM Names Three New Vice-Chairs
Congratulations to Laura Calvi, M.D., from the division of Endocrinology & Metabolism, who was named vice-chair for Basic and Translational Science, and to Valentina Kutyifa, M.D., Ph.D., from the Clinical Cardiology Research Center, who was named vice-chair for Clinical Research, and to Supriya Mohile, M.D., M.S., from the division of Hematology/Oncology, who was named vice-chair for Academic Affairs.
    Special Announcements  

Research Funding: Douglas Anderson, Ph.D., has been awarded funding from Scriptr Global Inc. for his lab at the Aab Cardiovascular Research Institute to develop trans-splicing technology to treat Duchenne muscular dystrophy.

Publications: Ann Falsey, M.D., from the division of Infectious Diseases, was first author on research published in the New England Journal of Medicine on the safety and efficacy of the AstraZeneca vaccine. Co-authors include Michael Keefer, M.D., interim division chief of ID.

Publications: Rebecca Levy, M.B.B.Ch., B.A.O., M.Sc., from the division of Nephrology, published research in the American Journal of Kidney Diseases on the association of GSTM1 deletion with progression of kidney disease in children.

In the News: Brian McGarry, Ph.D., from the division of Geriatrics & Aging, published a letter in the New England Journal of Medicine regarding nursing home staff vaccination rates that was covered by NBC News Health.

    Off the Clock  
Dave Dobrzynski, M.D., from the division of Infectious Diseases, is an avid golfer, along with his father, David Dobrzynski, M.D., a primary care physician. Here is the Dobrzynski family on a golf trip to Ireland in 2019. Dave Jr. and David Sr. are such fans of golf that they attended the Masters Tournament in 2016.
    Featured Tweet  
URMC Department of Medicine
The Levy Letter is always looking to learn about good things happening here!
Email us with your ideas.